1. Academic Validation
  2. Phenotypic spectrum associated with de novo mutations in QRICH1 gene

Phenotypic spectrum associated with de novo mutations in QRICH1 gene

  • Clin Genet. 2018 Feb;93(2):286-292. doi: 10.1111/cge.13096.
A Ververi 1 M Splitt 2 J C S Dean 3 DDD Study 4 A F Brady 1
Affiliations

Affiliations

  • 1 North West Thames Regional Genetics Service, London North West Healthcare NHS Trust, Harrow, UK.
  • 2 Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne, UK.
  • 3 Department of Medical Genetics, Aberdeen Royal Infirmary, Aberdeen, UK.
  • 4 DDD Study, Wellcome Trust Sanger Institute, Cambridge, UK.
Abstract

Rare de novo mutations represent a significant cause of idiopathic developmental delay (DD). The use of next-generation sequencing (NGS) has boosted the identification of de novo mutations in an increasing number of novel genes. Here we present 3 unrelated children with de novo loss-of-function (LoF) mutations in QRICH1, diagnosed through trio-based exome sequencing. QRICH1 encodes the glutamine-rich protein 1, which contains 1 Caspase activation recruitment domain and is likely to be involved in Apoptosis and inflammation. All 3 children had speech delay, learning difficulties, a prominent nose and a thin upper lip. In addition, 2 of them had mildly raised creatine kinase (CK) and 1 of them had autism. Despite their small number, the patients had a relatively consistent pattern of clinical features suggesting the presence of a QRICH1-associated phenotype. LoF mutations in QRICH1 are suggested as a novel cause of DD.

Keywords

CK; QRICH1; autism; developmental delay.

Figures